MedTrace Logo

The Effect of Ganoderma on Patients With Head-and-neck Cancer

NCT02238587 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-09-12

No results posted yet for this study

Summary

To study the effect of Ganoderma Spores Powder Capsules on the life quality and immunity status of the patients with head-and-neck cancer after complete treatment (including surgery and / or radiotherapy and/or chemotherapy)

Conditions

  • Head-and-neck Cancer

Interventions

OTHER

Control group

In control group, only placebos are given for 6 weeks. The patients who are in control groups are switched to receive Ganoderma Spores Powder Capsules for 6 weeks.

DIETARY_SUPPLEMENT

Ganoderma Spores Powder Capsules

In experimental group, Ganoderma Spores Powder Capsules for 12 weeks.

Sponsors & Collaborators

  • Chang Bing Show Chwan Memorial Hospital

    lead OTHER

Principal Investigators

  • Kuender D. Yang, PhD · Chang Bing Show Chwan Memorial Hospital

  • Ching-Yeh Hsiung · Chang Bing Show Chwan Memorial Hospital

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02238587 on ClinicalTrials.gov